Can a traditional chinese tablet reduce heart attacks and hospitalizations?
Disease control
Recruiting now
This study tests whether Yangxinshi tablets can improve outcomes for people with coronary heart disease and heart dysfunction. About 2,700 participants aged 40-80 will receive the tablet or a placebo. The goal is to see if the tablets reduce serious heart events like death, strok…
Phase: PHASE4 • Sponsor: SPH Qingdao Growful Pharmacetical Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC